Institut de Recherches Cliniques de Montréal, QC, Canada.
Blood. 2010 Feb 18;115(7):1354-63. doi: 10.1182/blood-2009-08-237370. Epub 2009 Dec 14.
HIV up-regulates cell-surface expression of specific ligands for the activating NKG2D receptor, including ULBP-1, -2, and -3, but not MICA or MICB, in infected cells both in vitro and in vivo. However, the viral factor(s) involved in NKG2D ligand expression still remains undefined. HIV-1 Vpr activates the DNA damage/stress-sensing ATR kinase and promotes G(2) cell-cycle arrest, conditions known to up-regulate NKG2D ligands. We report here that HIV-1 selectively induces cell-surface expression of ULBP-2 in primary CD4(+) T lymphocytes by a process that is Vpr dependent. Importantly, Vpr enhanced the susceptibility of HIV-1-infected cells to NK cell-mediated killing. Strikingly, Vpr alone was sufficient to up-regulate expression of all NKG2D ligands and thus promoted efficient NKG2D-dependent NK cell-mediated killing. Delivery of virion-associated Vpr via defective HIV-1 particles induced analogous biologic effects in noninfected target cells, suggesting that Vpr may act similarly beyond infected cells. All these activities relied on Vpr ability to activate the ATR-mediated DNA damage/stress checkpoint. Overall, these results indicate that Vpr is a key determinant responsible for HIV-1-induced up-regulation of NKG2D ligands and further suggest an immunomodulatory role for Vpr that may not only contribute to HIV-1-induced CD4(+) T-lymphocyte depletion but may also take part in HIV-1-induced NK-cell dysfunction.
HIV 上调感染细胞表面表达 NKG2D 激活受体的特定配体,包括 ULBP-1、ULBP-2 和 ULBP-3,但不包括 MICA 或 MICB,无论是在体外还是体内。然而,参与 NKG2D 配体表达的病毒因子仍未确定。HIV-1 Vpr 激活 DNA 损伤/应激感应 ATR 激酶并促进 G2 细胞周期停滞,这些条件已知可上调 NKG2D 配体。我们在此报告 HIV-1 通过一种依赖 Vpr 的过程选择性地上调原代 CD4+T 淋巴细胞表面 ULBP-2 的表达。重要的是,Vpr 增强了 HIV-1 感染细胞对 NK 细胞介导的杀伤的敏感性。引人注目的是,Vpr 本身足以上调所有 NKG2D 配体的表达,从而促进有效的 NKG2D 依赖性 NK 细胞介导的杀伤。通过有缺陷的 HIV-1 颗粒传递病毒相关的 Vpr,在未感染的靶细胞中诱导类似的生物学效应,这表明 Vpr 可能在感染细胞之外也具有类似的作用。所有这些活性都依赖于 Vpr 激活 ATR 介导的 DNA 损伤/应激检查点的能力。总的来说,这些结果表明 Vpr 是 HIV-1 诱导 NKG2D 配体上调的关键决定因素,并进一步表明 Vpr 具有免疫调节作用,不仅可能导致 HIV-1 诱导的 CD4+T 淋巴细胞耗竭,而且还可能参与 HIV-1 诱导的 NK 细胞功能障碍。